The network is coordinated by Pr. Odile Launay (Paris Descartes University).
The organization and strategic management are based on 3 decision-making bodies:
- The Studies Monitoring Committee (COS) made up of members of the former CoREIVAC steering committees.
- The Board of Directors (CA), made up of a representative of each of the partners and associated members.
- The steering committee (COPIL), made up of the network coordinator, the coordination team, the leaders
of the various workpackages, the members of the REIVAC steering committee and a representative of the EUCLID
platform (EUropean CLInical Trials Services Platform & Development ).
- The Studies Monitoring Committee (COS) made up of members of the former CoREIVAC steering committees.
All of these committees are assisted by a scientific council and an Inserm ethics committee.
The operational management of the network is based on the Works Packages Leaders (see diagram n ° 1 below) and the coordination team (cf. diagram n ° 2 below).
Schéma N°1 "les Works Packages Leaders":
Composition of I-REIVAC
Since its creation, the network has aimed to promote clinical research in vaccinology in France. Initially composed of four clinical investigation centers (CIC) (the CICs of Cochin and Bichat in Paris, Clermont-Ferrand and Montpellier) which formed the network's steering committee, the network then expanded to 18 centers including 7 CICs, 2 Clinical Research Centers (CRC),1 Clinical Research Unit in Immunology, 3 infectious disease departments, 1 epidemiology and prevention department and 2 localized immunology laboratories for PBMC extraction, located in Cochin and St-Etienne. I-REIVAC brings together partners with complementary expertise at national and European level: clinicians, immunologists, hygienists, epidemiologists, specialists in Human and Social Sciences.
